Growth Update - Turner Syndrome Practice Updates

Speciality: Physician (Internal Medicine)


Speaker:

Dr. Ahila Ayyavoo - Moderator | DCH, DNB (Paed), PhD Consultant, Paediatric Endocrinologist

Dr. Soundaram V - Speaker | Consultant Paediatric Endocrinologist,

Dr. Shobi Anandi V - Speaker | MD (Ped); DNB (Ped); Fellowship in Pediatric and Adolescent Endocrinology, Consultant Pediatric Endocrinologist

Description:

A warm welcome to all the medical professionals in this interesting session on Growth Update - Turner Syndrome Practice Updates
Turner Syndrome (TS) is a chromosomal disorder affecting females, characterized by partial or complete loss of one X chromosome. Recent practice updates emphasize the importance of early diagnosis and intervention to optimize growth and development outcomes. Growth hormone (GH) therapy has become a cornerstone in managing short stature associated with TS, with evidence showing significant improvements in height when initiated at an early age. Regular monitoring and individualized dosing are critical to maximize the benefits of GH therapy while minimizing potential side effects.
Advancements in genetic testing have improved the accuracy and speed of diagnosing Turner Syndrome, allowing for earlier and more precise interventions. These updates also highlight the importance of a multidisciplinary approach in managing TS, addressing not only growth concerns but also associated comorbidities such as cardiovascular, renal, and reproductive health issues. Comprehensive care plans involving endocrinologists, cardiologists, nephrologists, and reproductive specialists are essential to provide holistic care for individuals with TS.
Therefore, get an overall knowledge of Growth Update - Turner Syndrome Practice Updates
 

See More Webinars @ Hidoc Webinars




Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Patients with chronic myeloid leukemia who take nilotinib are at higher risk for diabetes and hyperlipidemia.

2.

More Data from Population-Based Studies Show CRC Screening Lowers Cancer Death Risk.

3.

What Role Should Genomic Classifier Testing Play in Prostate Cancer?

4.

A new mechanism of radioresistance formation demonstrated in lung adenocarcinoma

5.

Squeezing through tiny blood vessels may trigger melanoma cells to spread


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot